Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Using Gentamicin and Dexamethasone for Bronchiectasis Treatment

Official title: A Randomized Sham-Controlled Trial of Bronchoscopic Levofloxacin and Gentamicin Versus Sham in Mechanically Ventilated Bronchiectasis: Acute and 1-Year Outcomes

Run by Assiut University · NCT06209047 · Data updated 2026-11-12

This study tests whether using gentamicin and dexamethasone can help people with bronchiectasis who are on mechanical ventilation feel better and breathe easier during acute flare-ups.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment315 (estimated)
SponsorAssiut University
Academic / other
Locations1 site (Asyut)
StatusRecruiting
StartedOctober 15, 2023
Main results expectedMay 15, 2026
Study endsFebruary 1, 2027
Registry record updatedJuly 17, 2025
Trial IDNCT06209047 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with confirmed bronchiectasis and acute exacerbations requiring hospitalization.

Probably not a fit

Patients with active pulmonary tuberculosis or allergic bronchopulmonary aspergillosis may not benefit from this treatment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the safety and efficacy of local instillation of gentamicin and dexamethasone in patients with bronchiectasis experiencing acute exacerbations while on mechanical ventilation. The study aims to improve mucociliary clearance, reduce bacterial colonization, and alleviate airway inflammation through targeted treatment. Participants will undergo bronchoscopic airway clearance followed by the instillation of the medications to assess their impact on lung function and quality of life. The trial focuses on patients who require antibiotic treatment in a respiratory ICU setting.

Why it matters

Potential benefit: If successful, this approach could significantly reduce exacerbations and improve the quality of life for patients with bronchiectasis.

How similar studies have gone: While the specific combination of gentamicin and dexamethasone for bronchiectasis is novel, similar approaches targeting bacterial colonization and inflammation have shown promise in other studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients with bronchiectasis confirmed by high-resolution CT chest(HRCT)
* patients with acute exacerbation of bronchiectasis who need antibiotic treatment at the hospital due to exacerbation
* mechanically ventilated patients in the respiratory ICU
* Age more than or equal to 18 years

Exclusion Criteria:

* patients with active pulmonary tuberculosis
* patients with allergic bronchopulmonary aspergillosis
* patients who underwent interventional bronchoscopy for hemoptysis
* age less than 18 years

Where it's running

  • Assiut university hospitals
    Asyut, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.